Category: Sciences

This new accreditation certifies the eCOA technology platform

TransPerfect Life Sciences, a leading provider of services and technologies supporting global clinical trials and product development for the biopharmaceutical industry, today announced the use of its certification solution to certify its electronic clinical outcome assessment (eCOA) technology platform based on host capacity. eCOA is local content aligned with industry standards, best practices and sponsorship requirements.

The solution, called the LingCert eCOA, has three levels of certification: Silver, Gold and Platinum. Each level is awarded based on ability to meet operational success criteria across four platform categories:

• Content management
• internationalization
• Test after translation
• Ability to reuse content

Some recent recognition in the field, including the ECOA Clario tablet, has helped draw attention to platform enhancements that offer 360-degree progress.

“TransPerfect's new certification helps differentiate COA offerings in the marketplace by making it easier to demonstrate that we provide a superior experience to our customers and their patients,” said Terry Burke, Clario's Executive Vice President of eCOA.

LingCert's eCOA was designed to alleviate the challenge of delivering electronically migrated COAs to clinical trial participants, where any errors ultimately increase costs and delays. With this certification, the eCOA platform is also well positioned to reduce translation costs and improve the overall quality of eCOA by meeting backers' expectations.

The newly recognized clinical ink platform paves the way for additional levels of process excellence across the company's technology suite.

Megan Petrelak, Executive Vice President of Client Experience at Clinical Inc. Partnership for Harmonized Structures allows us to reliably measure compliance with industry standards and helps us characterize the conversations with sponsors that are most important to them.

“We are excited to introduce the LingCert eCOA certification program,” said Phil Shaw, President and CEO of TransPerfect. “This certification provides our customers and life science partners with a one-stop approach to hosting local ECOA materials.”

Learn more about TransPerfect's eCOA solutions at [email protected].

About Clario

Clario is a leading healthcare research and technology company providing our partners with the most comprehensive clinical data in the pharmaceutical, biotechnology and medical device industries. Through decentralized, hybrid, and on-site testing, our deep scientific expertise, global reach, and industry-wide endpoint technology platforms enable our partners to change lives. Clario's digital eCOA solution has enabled hybrid and decentralized clinical trials (DCT) for more than 20 years, enabling sponsors to collect high-quality endpoint data from any method and any location, enhancing patient experience and versatility. Clario has the only technology platform that integrates eCOA, cardiac safety, medical imaging, precision movement and respiratory endpoints. Clario's global team of 30 medical centers in nine countries has helped conduct more than 19,000 studies and received 870 regulatory approvals for more than 5 million patients in 120 countries. Our innovations have transformed 50 years of clinical experience.

About Clinical Ink

Clinic Inc. It is a global life sciences company that brings data, technology and patient research together. Our deep expertise in treatment combined with advances in live data collection, eCOA, eConsent, telemedicine, neurocognitive testing, and digital biomarkers is setting the industry standard for data accuracy and opening up a new generation of clinical trials. Using digital data, we are helping sponsors, client service providers, investigators, and patients recreate decentralized trials and rewrite clinical development experiences.

About Transperfect Life Sciences

TransPerfect Life Sciences supports the global development and commercialization of medicines, treatments and devices designed to improve and save lives. Our end-to-end solutions include eTMF technology, eClinical, TMF paper migration, pharmacovigilance and security solutions, translation and language services, and call center support. With offices in over 100 cities worldwide, Transperfect is the ideal partner to ensure the global impact of your global launch. For more information, visit our website at https://lifesciences.transperfect.com/

About Transperfect

TransPerfect is the world's largest provider of enterprise language and technology solutions. From offices in more than 100 cities on six continents, TransPerfect offers customers worldwide a variety of services in more than 200 languages. More than 6,000 organizations worldwide use TransPerfect GlobalLink® technology to simplify multilingual content management. With an unparalleled commitment to quality and customer service, TransPerfect is fully ISO 9001 and ISO 17100 certified. Transperfect is headquartered in New York with regional headquarters in London and Hong Kong. For more information about TransPerfect, visit https://www.transperfect.com.

© Tammy Grubb/The Herald-Sun/TNS After Longfellow Real Estate Partners acquired the building on W. Franklin St. in Chapel Hill. At 306, the Purple Bowl has become a loyal and diverse customer base to stop what appears to be a move.

A life sciences project that has sparked a campaign to save a popular restaurant could create the tallest building in downtown Chapel Hill and involve more land than expected, a city advisory board found Tuesday night.

The proposed Chapel Hill Life Sciences Center would add approximately 320,000 square feet of laboratory, office and retail space at 306 W. Franklin St. The project could include storefronts on West Rosemary Street and a 320-space parking garage.

The building will be on the lower Franklin Street elevation and will be 150 to 160 feet tall, project officials said. The lab space includes a 20-foot mechanical ceiling, making it the tallest building downtown.

©Tammy Grubb/The Herald-Sun/TNS In 2022, Purple Bowl owners Taylor and Paula Gilland expanded into the nearby commercial space and attempted to purchase the building from the owner. They lost the bid to Longfellow, who paid $13.2 million for the building and four other lots, documents show.

A wet lab and office building permitted on the hill at the east end of Rosemary Street may be 140 feet including a mechanical attic. It's five feet taller than Greenbridge's controversial 601 W. Rosemary St. in 2007 and 35 feet taller than the 140-unit West Franklin, which opened in 2013.

©Tammy Grubb/The Herald-Sun/TNS Texas developer W. Franklin St. Built a 140 x 150 foot biology center at 306 Chapel Hill.

Boston-based Longfellow Real Estate Partners paid $13.2 million last year to buy the five lots that make up the project site, county records show. The land includes three parking spaces and a fifth third bank, which is not part of the redevelopment.

It will replace a 1/2-story building that houses several businesses, including Blue Dogwood Public Market Food Hall, Chimney Indian Kitchen and Bar and Purple Bowl.

Chapel Hill, a startup accelerator and co-working space founded by UNC, the city and Orange County, will move from the building to a new innovation center at 137 E. Franklin St. in February. and 136 E. Rosemary St. He has moved.

Another longtime company, the Bicycle Network, could also be added to the mix, creating a 2.23-acre project site, the Community Planning Commission learned Tuesday. Greg Capps, chief executive officer of Longfellow Real Estate Partners, is in talks with the store's owner, who lives in Carrboro, but no deal has been reached yet.

The council will be able to review the concept plan on March 22 and provide feedback that will be used to prepare for formal action.

The council is to redevelop the City Center 3 site to accommodate a taller, more residential building. Traffic, parking and stormwater can be significant issues as the site is prone to flooding.

Save the Purple Bowl campaign.

After Longfellow announced the project in November, Purple Bowl employees and fans flooded the city with letters and phone calls hoping to save the company.

In an interview with The News and Observer last year, owner Taylor Gilland said he and his parents knew the owner wanted to sell and had offered to buy the building last year and were looking for a $500,000 expansion on an adjacent lot that closed.

Gilland, who founded the business with his parents in 2017, has talked with Durham investors and brewers about adding a beer garden and 10,000 square feet of space. He said they reached out to Longfellow about their options over the summer and received multiple responses. They were surprised when the project was announced in November.

Gilland told commissioners Tuesday that Chapel Hill's "college town charm" is something that I think other cities are doing their best to achieve and that everyone across the country is talking about.

"If they had, I think they would have protected him and fired him," he said. "Over the past five years, we've thrown away the reputation and character of Chapel Hill … instead of investing in older buildings."

His mother, Paula Gilland, was joined by about a dozen other presenters, including Purple Bowl staff, UNC residents and students, athletes and alumni.

UNC graduate Varun Jain said he grew up in Singapore and Australia, but was overseas for the Purple Bowl.

“If Chapel Hill continues to be a growing destination that draws people from across the state, the country and the world, businesses and organizations like the Purple Bowl will bring that feeling to life, and a small town like Chapel Hill. It really is. "community and have a personality that I think is unique to a lot of other places," Jane said.

Lanier Hodgson joined her husband Scott and their young children on screen for a virtual reunion. As Hodgson talked about the importance of small businesses to families visiting the city, his daughter Bailey waved and sang "Purple Bowl!" the song. He smiled widely as he stopped whispering.

"If the city of Chapel Hill is going to continue to build what makes this city special, we have to maintain the best brand, and this is where we build community, and that's what this Franklin Street will do," Hodgson said.

City Hall reacts to Longfellow's project

While there was "extraordinary emotion on the part of various people," CDC Chairman John Weiss said the commission only looked at the design of the project, not the use of the building. He later asked the developer to take note of the comments.

"You have to look at the people who have expressed their appreciation for using it and what it means to Chapel Hill," Weiss said.

Other commissioners asked many questions, but few commented, citing a lack of information about parking in some cases and the possibility that could change if a developer buys the bike chain property.

Commissioner Megan Patnaik wanted to know how the project would reflect the Franklin Street community and its voice.

"I hear the Lab and Rosemary on Franklin Street are going to build, I think it makes sense, but it's a small place for people to eat and drink," he said.

The site was chosen for its size, which is rare in downtown Chapel Hill, and because it offers the opportunity to create a public space unavailable on the city's west end, said project architect Michael Stevenson. Senior project manager Nathan Zeidler said the team is working to reduce the building's visual impact.

Commissioner Ted Hoskins is reviewing the project, but suggested the developer reconsider some of the suggestions made by Planner Brian Peterson, such as: b. Divide the building into two parts and reduce the visual impact of the project.

Longfellow should consider relocating existing tenants, not putting them out of business, Weiss said.

"The thing is, you're basically looking at a zoning change here, and the city can ask you to do something like that in lieu of a zoning change," Weiss said.

The anxiety over the Purple Bowl means more than a loss of business, Taylor Gilland told the N&O when asked if city leaders are more financially motivated than residents would like.

"I think there's a lot of frustration downtown with the pace of commercial development in the Chapel Hill community," Gilland said. "We're moving from a nice little downtown to a corporate development with plenty of space in the new buildings that are now open."

UNC Startups, New Businesses

In the last decade, two- and three-story buildings in Chapel Hill have been replaced by tall buildings. The city has focused on creating more work and residential spaces downtown, created in part by UNC startups that need space to grow.

Charlotte-based developer Grubb Properties is renovating the former CVS building downtown on East Franklin Street at 150 E. Rosemary St. St. construction can begin as soon as the parking lot is completed.

The Grab projects are part of Innovation Hub's partnership with UNC-Chapel Hill and the Innovate Carolina program, which provides local entrepreneurs and startups with business accelerators, access to talent and prospective investors, and other development services.

Michelle Bolas, UNC's chief innovation officer and chief executive officer of Innovate Carolina, told The N&O last year that the center could serve 400 UNC-affiliated startups.

Relocation or Closure Decision

City officials say Chapel Hill's downtown business district has a long history of losing revenue due to high land prices, high rents and a lack of year-round residents and customers. But new businesses want to move downtown, which has 200 street shops, said Matt Gladek, executive director of the Chapel Hill Downtown Partnership.

Gladek and Mayor Pam Hemminger told the N&O they have made offers to help businesses at 306 W. Franklin St.

"It's scary when you think about moving your business, but increasing the number of businesses and workers downtown will help build a more sustainable economy and help everyone prosper," Hemminger said.

"I know they're upset, but they knew it was coming, and it's a two-year window of opportunity, so we have plenty of opportunities to help them move to a new location downtown or learn how to do that." "The change will be built and come back during the construction," he said.

Paula Gilland said there are many options for relocation, including the UNC-owned store at 122 E. Franklin St. He said the timing was wrong for the space that formerly housed Benny's Cappella Pizzeria.

Another commercial space has yet to be approved on the ground floor of Grubb Properties' seven-story Rosemary Link apartments. Paula Gilland also said they felt uncomfortable taking the seat because it could have been reserved for a minority company.

©2023 Raleigh News and Observer. Visit newsobserver.com. Distributed by Tribune Content Agency, LLC.

YaleAREA 2022 conference – Panel. Life Sciences, Real Estate Development 101 College St., New Haven

© Harry Zernick; Scribner author Kate Zernick and her book Exceptions.

Nancy Hopkins and 15 MIT colleagues teamed up in the 1990s to show gender differences among teachers. The Massachusetts Institute of Technology agreed, and these changes helped bring about a sea change for women in all academic and research settings. How did this happen? Pulitzer Prize-winning journalist Keith Zernick tells his story in his new book, Exceptions (Scribner, February). In this Q&A, she talks about the achievements she's helped create, the challenges women in STEM still face, and what's key to ensuring equal opportunities for girls and women in science.

Question: Why are you writing this book? why now

A: I started thinking about writing this book in January 2018, just as the #MeToo movement was starting to grow. These dire circumstances got me thinking about the kind of discrimination women were talking about at MIT in 1999: the hidden ways women are marginalized in the workplace, especially as they get older. I think it's more common and subtle. One of the key points the women at MIT made was that opening doors for women is not enough, you have to make sure you value them and treat them as equals in their careers. What struck me was that the challenges women face in science highlighted a larger problem, which is that we still don't take women seriously in intellectual and professional circles. This story is even more relevant now that the country is once again debating whether we need affirmative action. These women believed that there would be pure meritocracy with an emphasis on scientific data and facts. You discover that there is no such thing.

The efforts of Nancy Hopkins and her colleagues led to advances in academic scholarship. Has it influenced other science fields and STEM careers?

When the MIT report was published, MIT had never had a department head. Today, women lead the university, from the board of trustees to the president and dean of science. (Like the states of Massachusetts and the city of Boston). Back then, the Ivy League had only one female president, and this fall, six of those eight organizations are led by women. This is a small elite segment, but these universities are good at spotting trends. There are other subtle changes: when MIT women first began to address the issue, no female professors took maternity leave because of stigma. Professors at many universities now say that they are no longer the exception when colleagues send their children to day-care centers that didn't exist in 1999. Universities usually stop teaching when women (and men) have children. The President of the National Academy of Sciences and three of President Biden's top science advisers are all women, as are the people leading vaccine development as the world battles the COVID-19 pandemic. Yet very few women win the Nobel Prize in Science, reminding us that we still have a long way to go in terms of education and women's contribution.

Given the pay gap between women and men in STEM positions, how important is the MIT Group? What comes after the fight?

In most regions, women are still paid less than men for the same work. There is nothing a group of women at a university can do about that, it all depends on the men and women who run companies and universities. The women at MIT had no idea the report would be read off campus. But the excitement surrounding her story prompted other universities to run similar tests. It also prompted the National Science Foundation to create a program aimed at eliminating inequalities in teaching approaches, grant awarding, and propensity for employment.

The number of women entering science and technology colleges is still disproportionately high. A 2018 report by the National Academies of Sciences, Engineering, and Medicine found that nearly half of the women at these colleges have been sexually abused. A small percentage of these disorders are linked to sexual assault. By far the biggest problem was what the report called "gender harassment" by women at MIT. These are sexual slurs against women in science, rude comments that make women feel unwelcome in this environment. This is especially true for doubly marginalized women: women of color, lesbians, or women we traditionally see as masculine in appearance or behavior.

When Larry Summers, then-president of Harvard University, commented on women's "internal problems," it sparked another storm of controversy on the subject. How many people still think women's progress in this area is "extraordinary"?

I followed this story closely in 2005, but when I came back I was shocked to see a spate of articles defending Larry Summers, despite much research to refute his claims. Some of her ideas – not only that women lack inner strength, but also that they don't want to work 80 hours a week – have been around since the beginning of the last century. I think there is a lot of awareness now. “Exclusions” also points out how these women articulate subtle forms of discrimination; They assumed it was due to circumstances or blamed themselves. I think we now have a better understanding of systemic bias.

Nancy's report was never published. Why? Do you think the information there can help current and future women who want to break the glass ceiling?

The Massachusetts Institute of Technology has not released the full report because it contains stories by or about professors that are subject to confidentiality. You cannot anonymize these stories. Even the word "junior math teacher" would indicate a woman, for there were one or two of them. The stories are in the book and I think they illustrate the assumptions and patterns women still have to work with and the pitfalls to avoid.

What was the most surprising thing you learned from reading this book?

That shouldn't surprise me and us, but we were reminded of how long we've been talking about the same problems, even finding solutions, but doing nothing. President Kennedy's Women's Commission recommended paid maternity leave in 1963; It took decades to get it. Research conducted in the 1970s showed that we all, men and women, valued the same CV less if it had a woman's name on it rather than a man's. It's a reminder that every generation thinks it has solved a problem, but every generation reinvents it.

What is the key to ensuring equal opportunities for girls and women in science?

Changing attitudes is key when it comes to hiring institutions and talking about who does the most important work in science. Who comes to mind when we hear the word "genius" – research shows that it's mostly men. MIT's School of Engineering made strides toward hiring more women after the report, as a male dean refused to chair re-education committees, as he often does, saying women were not eligible for the appointment. He said look again.

Related Articles

Start an unlimited Newsweek trial

Women are the key to economic development

Is Etsy's Growth Story DESTRUCTED? ($ETSY Q2)

The Life Sciences Voice (LSV) Best Industry Leaders Award recognizes industry leaders who advance the industry through their high-impact work.

NEW YORK , Feb. 23, 2023 /PRNewswire/ — Life Sciences Voice is pleased to announce the winners of the 2022 Top Industry Leaders Awards. The list includes influential leaders who are driving the industry forward with their transformative work. The LSV team is honored to celebrate this outstanding list of winners who continue to inspire us with their leadership, results-oriented and measurable impact.

The LSV Awards team faced the incredibly difficult task of selecting winners from a large number of nominations across all industries and functional areas. Our community and research team put a lot of effort into evaluating and selecting a diverse list of winners. These leaders continue to find innovative ways to advance excellence in their fields. They fully understand how science needs to be aligned with business and patient needs and are able to deliver benefits to stakeholders – patients, employees, healthcare partners, investors and more.

Ian Coolidge, editor of Life Sciences Voice, says. “We saw several major trends impacting our industry in 2022. These included internal changes in the industry accompanied by external changes such as social, economic and geopolitical changes, technological advances and changes in consumer behaviour. company and their differentiation in this turbulent environment”.

The announcement of the LSV Top Industry Leader Awards, one of the most anticipated in the industry, helps thousands of community members identify nominees and contribute to the selection of winners. The list of Best Industry Leaders in Life Sciences Awards 2022 winners is available online.

The story continues

The Voice of Life Sciences community invites industry professionals, their friends and loved ones to join the celebration and congratulate the winners!

About the Voice of Life Sciences

Life Sciences Voice (LSV) is the premier resource for life sciences executives to find key insights, explore the latest innovations, and learn about industry news and trends. The Biomedical Sciences Voice for the Community provides thought-provoking commentary in a variety of formats covering a wide range of industry topics.

Media contacts:

Nick Narral
908-441-8341
http://lifescivoice.com/

Check out the original downloaded media content:

Voice of Life Science Source

Cyberpunk Documentary Part 1 | Neuromancer, Blade Runner, Robocop, Akira, Shadowrun

BUFFALO, NY – The University at Buffalo's Center for Integrative Global Biomedical Sciences (CIGBS) has become a member of the Abbott Pandemic Defense Coalition, the industry's first global public health and health science coalition dedicated to early detection and response. soon in the future pandemic. threats

As part of the coalition, Gene Morse, PharmD, professor emeritus of pharmaceutical practice at SUNY US School of Pharmacy and Pharmaceutical Sciences, will be the principal investigator, providing expertise and conducting research to expand testing capacities and initiatives. Education on coalition sites.

The Abbott Pandemic Defense Coalition was formed to identify, detect, analyze and test emerging global threats, including variants of COVID-19. As Director of CIGBS and Co-Director of the Institute for Global Health at the State University of New York, Morse will work with a network of more than 20 scientific, academic and public health organizations on five different continents to build a network of "Frontline". . “Monitoring infrastructure for emerging and existing virus threats, including:

• Discover and track new pathogens and analyze how known viruses are changing
• Providing and sharing sequencing data to determine if a virus is a known or unknown pathogen
• Do follow-up testing to understand how many people have contracted the virus, where it has spread, and possible risk factors.
• Rapid development and implementation of diagnostic tests, if necessary using first case studies
• Educate the next generation of epidemiologists and virus hunters to be prepared for future pandemic threats

"This is a great opportunity to join other CIGBS efforts, including the Global Viral Network (GVN), and share the years of experience of our UB team mentors with a coalition of young scientists from different countries," Morse said.

Morse is also the principal investigator of several programs funded by the National Institutes of Health (NIH) Fogarty International Center, including the US-Zimbabwe HIV Training Program and the UB-West Indies Global Infectious Disease Research Training Program. He is also the primary mentor to two NIH Fogarty Emerging Global Leader Award winners in South Africa and Nigeria. CIGBS is a global center of excellence in virus control with sister centers in Jamaica, Trinidad and Tobago and Zimbabwe. "We plan to bring our integrated biomedical science model to Abbott's pandemic defense coalition and establish new partnerships with GVN centers and capacity-building programs such as FIC initiatives," says Morse.

"Global collaboration is needed more than ever to help us prepare for and prevent future virus outbreaks," said Gavin Cloherty, Ph.D., director of the Coalition and Abbott's head of infectious disease research. "UB's addition to the Abbott Pandemic Coalition will help train a new generation of young scientists and build strong capacity at new evidence-based surveillance sites in low- and middle-income countries to stay ahead of the next virus threat."

"UB's anticipated role in the coalition is excellent recognition of the high-quality programs and interdisciplinary approach that CIGBS fosters in its global research initiatives," said Gary Pollock, Ph.D., Dean of UB College of Pharmaceuticals.

Other university professors who have contributed to CIGBS' growing expertise on emerging pathogens include Andrew Talal, Timothy Murphy, Stanley Schwartz, John Tomaszewski, Oscar Gomez, Mark Hikar and Amy Jacobs, all from the School of Medicine and Jacobs Biomedical Sciences. ; Brian Tsuji, Qing Ma, Raymond Cha, and Robin DiFrancesco, all from the College of Pharmacy and Pharmaceutical Sciences; and Troy Wood and Paras Prasad from the College of Arts and Sciences.

Opportunities and perspectives in the field of mechanical engineering

Go to Life Sciences, Inc. If you want to know who controls (NASDAQ: ACHV ), you'll have to look at the composition of its stock register. With a 56% stake, individual investors own the majority of the company's shares. In other words, the group faces most of the upside potential (or downside risk).

Institutions in turn represent 43% of the company's shareholders. Large companies tend to have institutions as shareholders and we often see insiders owning shares in smaller companies.

Let's dive into each type of owner at Achieve Life Sciences, starting with the table below.

See our latest analysis of Achieve Life Sciences

What does institutional ownership tell us about outcomes in the life sciences?

Institutional investors often compare their returns to the returns of an index they typically track. Therefore, they often consider buying larger companies included in the standard.

As you can see, institutional investors have a large stake in Achieve Life Sciences. This may indicate that the company has some credibility in the investment community. However, it is best to avoid trusting institutional investors in the supposed validation that comes with it. Sometimes they are even wrong. It is not unusual to see a sharp drop in the stock price if two large institutional investors try to sell a stock at the same time. So it's worth taking a look at Achieve Life Sciences' past earnings history (below). Of course, keep in mind that there are other factors to consider.

Hedge funds do not own many shares of Achieve Life Sciences. Our records show that B. Riley Capital Management, LLC is the largest shareholder with a 20% stake. By comparison, the second and third largest shareholders own approximately 7.6% and 3.1% of the shares.

Based on our ownership data, 25 major shareholders collectively own less than 50% of the share register, meaning that no one person owns a controlling interest.

the story continues

While it makes sense to look at data on a company's institutional ownership, it also makes sense to look at analyst sentiment to see which way the wind is blowing. Few analysts cover stocks, so you can analyze the projected growth quite easily.

Achieve primary life sciences property

The definition of inside information can be subjective and varies by jurisdiction. Our data reflect individual insider information, capturing at least board members. Management is ultimately accountable to the board of directors. However, it is not uncommon for managers to be board members, especially if they are founders or CEOs.

Most view insider ownership as positive because it can indicate that the board is well connected to other stakeholders. However, sometimes too much power accumulates within this group.

Our most recent data shows that board members own less than 1% of Achieve Life Sciences, Inc. Board members appear to own no more than $883,000 in stock in the $104 million company. Many small business investors prefer to see a larger investment chart. You can click here to see if these experts are buying or selling.

general public property

The general public, consisting primarily of individual investors, collectively owns 56% of Achieve Life Sciences' stock. This level of ownership gives traditional investors some power to change key policy decisions, such as board composition, executive compensation and dividend payout rates.

Next steps:

It is always useful to think about the different groups that own shares in a company. But to better understand Achieve Life Sciences, we need to consider many other factors. Please note that Achieve Life Sciences shows 4 warning signs in our investment analysis , 2 of which should not be ignored…

If you're like me, you may wonder if this business will grow or shrink. Fortunately, you can check out this free report that shows analysts' predictions for the future.

NOTE: The figures in this article are calculated using data for the last twelve months, covering the 12-month period ending on the last day of the month following the balance sheet date. This may not be consistent with the reported data for the full year.

Have an opinion on this article? Worried about content? Contact us directly. You can also email the editorial staff at (at)Simplywallst.com.

This article on Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodologies and our articles are not intended to be financial advice. It is not a recommendation to buy or sell shares and does not take into account your financial objectives or situation. Our goal is to provide focused long-term analysis based on fundamental data. Please note that our analysis may not take into account recent company forecasts based on price or quality data. Simply Wall St has no position in the stocks mentioned.

Participate in a paid user research session
You'll receive a $30 Amazon gift card for one hour of your time, which will help us create better investment vehicles for individual investors like you. register here

Glendale, CA-based utility Titan is nearing an initial public offering

NexPoint, a billion-dollar alternative investment firm, has proposed plans to build a 200-acre, 4 million-square-foot life sciences facility in Plano on the former Electronic Data Systems campus. Called the TxS (Technology x Science) District, the project is centered around the 91-acre main campus and another 109 acres in the adjacent Legacy District.

The first and second phases of the campus will consist of four construction phases and include 970,000 square feet of labs and offices along with 120,000 square feet of office space. Initial plans for the site also include a community park, an amphitheater and a connection to the nearby Legacy commercial development.

NexPoint, which bought the main campus in 2018 and the surrounding land since then, is looking to build the campus through a public-private partnership. "This project will not only be a major economic catalyst for the region, but will also establish North Texas as a leader in the life sciences," said James Dondera, founder and director of NexPoint.

Architectural engineering and construction studio CRB International is collaborating on the project. JLL is in talks with NexPoint to become the leasing agent for the project.

"The TxS project will be unique in its ability to support life sciences companies at every stage of the process: discovery, early development and commercialization," says JLL's Matt Daniels. "With state-of-the-art research facilities, new federal policies that favor drug repatriation, and a tight labor market at coastal biomedical centers, Plano is poised to become a top choice for companies looking for expansion and solutions."

Flowserve agrees to acquire Velan for $245 million

In an all-cash deal, Dallas-based flow control products provider Flowserve has agreed to acquire Velan, an industrial valve maker, for $245 million. The transaction consists of $209 million of Velan's issued and outstanding equity capital and $36.3 million of total outstanding debt. Flowserve will also receive $31.4 million in free cash from Velan.

Velan, which has 1,650 employees in nine countries, reported revenue of $380 million for the 12 months ending November 2022. Upon completion of the transaction, Velan will become part of Flowserve's Flow Controls division. Within two years of closing, Flowserve expects to earn $20 million in operating cost synergies.

"We are very excited to have Whelan and his talented team join the Flowserve family," said Scott Rowe, Flowserve President and CEO. "With its strong position in the nuclear, refrigeration, industrial and defense markets and a highly complementary product portfolio, the addition of Velan contributes to our diversification, decarbonisation and digitalization strategy."

Mi Cocina is expanding with M Crowd in Houston

In May 2022, Edgar Guevara, CEO of M Crowd Restaurant Group, told the CEO of D Corporation that Mi Cocina was looking to expand into Houston. Now with 22 Mi Cocina locations in Texas and Oklahoma and a 23rd in McKinney this spring, M Crowd is officially expanding its exclusive Tex-Mex location in Houston.

The new restaurant is expected to open next October and create 80 to 100 new jobs.

Since March 2018, when Guevara took over as CEO of M Crowd Restaurant Group, the company's revenue has grown from $1 million to $1.5 million annually. Looking to the future, Guevara said his goal is to open two Mi Cocina's a year and expand into more national markets.

"Once we have a significant number of years, we can do more," says Guevara. “I think our product will do really well [in Houston]. And our real estate model also says that Denver and Atlanta are ready for development. There are smaller cities, but our model is to try to build four or five .Houston, build a big aircraft carrier there, and then go to another big market."

A new $125 million manufacturing facility is opening in Midlothian

SunOpta, a publicly traded Minneapolis vegetable company, has opened a new, 285,000-square-foot, $125 million manufacturing facility in Midlothian. The new plant will create about 175 new jobs.

The enterprise will produce a full line of dairy and non-dairy spreads, tea and other products. The new facility, the largest in the company's portfolio, will serve as a driving force for the company to achieve its goal of doubling its factory business by 2025 as it has nearly $200 million of investment in new manufacturing capacity at its facility.

The factory can expand to 400,000 square feet.

The plant footprint will reduce more than 15 million freight miles annually, and the company says the plant will reduce carbon emissions by 59 million pounds. In addition, the facility has installed water reuse equipment that can save up to 20 million gallons of water annually, an energy-efficient HVAC system that reduces energy use by 45%, and LED lights and water heaters that reduce energy use by 95% . %. %. . , offices and laboratories built with at least 40 percent recyclable materials.

writer

Ben Swanger is the editor-in-chief of D CEO , the professional publication of D Magazine . Ben runs the Dallas 500 team monthly…

Practical: Alumni Symposium | Sydney Gross Symposium